A PREDICTIVE AND COMPARATIVE STUDY VIA VIRAL AND BIOCHEMICAL MEASUREMENTS FOR RESPONDERS AND NON-RESPONDERS EGYPTIAN HEPATITIS C PATIENTS TO DACLATASVIR PLUS SOFOSBUVIR THERAPY
Most of the liver diseases and hepatocellular carcinoma (HCC) worldwide is due to infection with hepatitis C virus. The developed new drugs in the last few years are promising, but patients response to such drugs are different. Therefore, to identify early the non-responding patients to SOF/DCV ther...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Al-Azhar University, Faculty of Pharmacy
2018-09-01
|
| Серии: | Al-Azhar Journal of Pharmaceutical Sciences |
| Предметы: | |
| Online-ссылка: | https://ajps.journals.ekb.eg/article_46639_2c1e842895b035d5f53935d711f98ed8.pdf |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|